Olema Pharmaceuticals
OLMA
OLMA
195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
15.73% less ownership
Funds ownership: 132.15% → 116.42% (-16%)
33% less capital invested
Capital invested by funds: $2.27B → $1.51B (-$755M)
73% less funds holding in top 10
Funds holding in top 10: 11 → 3 (-8)
Holders
195
Holding in Top 10
3
Calls
$41.3M
Puts
$11.1M
Top Buyers
| 1 | +$119M | |
| 2 | +$45.7M | |
| 3 | +$32.4M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$25.6M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$22M |
Top Sellers
| 1 | -$28M | |
| 2 | -$27.2M | |
| 3 | -$26.7M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$23M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$14.2M |
